SGK-3-PROTAC-1

N/A

Report date: 2022/12/29 14:21:04
NME

Base Information

Drug NameSGK-3-PROTAC-1
Drug Alias NameSGK3-PROTAC1SGK-3-PROTAC-1
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSerine/threonine-protein kinase Sgk3 degraders
TargetsSerine/threonine-protein kinase Sgk3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Dundee
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Dundee
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A